Approved indication:
  • Renal conditions: to induce a diuresis or remission of proteinuria in nephrotic syndrome, without uremia, of the idiopathic type or that due to lupus erythematosus14

  • Reduce expression of inflammatory proteins by activating or inhibiting transcription of inflammatory related genes within the immune system15

  • Based on classification, symptoms, and progression of disease
  • Oral, intramuscular injection, or IV infusion

Adverse effects:
  • Fluid retention, potassium loss, hypertension, hypokalemic alkalosis, sodium retention14

Types of glucocorticoids:
  • Oral
    • Prednisone
    • Prednisolone
    • Dexamethasone
    • Methylprednisolone
  • Injection/IV
    • Dexamethasone
    • Methylprednisolone14

Treatment for: